Imagine having symptoms that could be leukemia, but you can't get to a specialist for the complex tests needed to confirm it. This is a reality for many people around the world. A team looked at whether an artificial intelligence (AI) tool could help by using just the results from standard blood tests to predict the type of leukemia a person might have. They tested it on a large, diverse group of over 6,200 patients from 20 different centers worldwide. The tool was very good at spotting certain types, like acute myeloid leukemia and a specific subtype called promyelocytic leukemia. But there was a big catch: to get that high accuracy, the tool had to refuse to make a prediction for the vast majority of patients—between 71% and 93% of the time. That's not very helpful for doctors. So, they refined the tool using a different method. This new version was less likely to refuse a prediction, excluding only about 12% of patients, and its accuracy for spotting acute myeloid leukemia in those uncertain cases improved. They also specifically retrained the tool to work better for children. The work shows that AI could one day be a useful support tool, helping more people get a faster, initial indication of their condition using tests they can already get.
Can a simple blood test help diagnose leukemia? An AI tool shows promise but still needs work.
Photo by Florian Krumm / Unsplash
What this means for you:
An AI tool can predict leukemia types from basic lab work, but it needs to be more confident to help most patients. More on Acute Leukemia
Meta-analysis links perinatal factors to childhood acute leukemia risk Perinatal factors linked to higher leukemia risk in children
· May 1, 2026
Long-course venetoclax with hypomethylating agents in unfit AML patients shows stable efficacy and MRD prognostic value. Frail Leukemia Patients See Better Results With New Blood Monitoring
Frontiers · Apr 21, 2026
Itacitinib plus standard therapy in acute leukemia or myelofibrosis patients undergoing reduced-intensity conditioning donor stem cell transplantation Early trial explores itacitinib for stem cell transplant patients with blood disorders
CT.gov · Apr 13, 2026